Cell biology of tissue factor, the principal initiator of blood coagulation

Thrombosis Research

Volumn 81, Issue 1, 1996, Pages 1-41

  Camerer, Eric ^a   Kolstø, Anne Brit ^a   Prydz, Hans ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Apical membrane domain; Calcium transients; Factor VII; Gene expression; Species specificity; Tissue factor

Indexed keywords

THROMBOPLASTIN;

BLOOD CLOTTING; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030070996     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00209-X     Document Type: Article

References (295)

1. LOEB, L. Weitere Untersuchungen über Blutgerinnung. Beitr Chem Physiol Pathol 5, 534-557, 1904.
2. MORAWITZ, P. Beiträge zur Kenntnis der Blutgerinnung. Beitr Chem Physiol Pathol 5, 133-141, 1904.
3. RIVERS, R.P., HATHAWAY, W.E. and WESTON, W.L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3), 311-316, 1975.
4. LYBERG, T., GALDAL, K.S. and PRYDZ, H. Synthesis of Thromboplastin in Endothelial Cells. Second International Symposium on the Biology of the Vascular Endothelial Cell, Cambridge, UK, (Abstract No. 47) (1981).
5. ØSTERUD, B. and RAPAPORT, S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74(12), 5260-5264, 1977.
6. WARR, T.A., RAO, L.V. and RAPAPORT, S.I. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 75(7), 1481-1489, 1990.
7. DAY, K.C., HOFFMAN, L.C., PALMIER, M.O., KRETZMER, K.K., HUANG, M.D., PYLA, E.Y., SPOKAS, E., BROZE, G.J., JR., WARREN, T.G. and WUN, T.C. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood 75(8), 1538-1545, 1990.
8. LAU, L.F. and NATHANS, D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 84(5), 1182-1186, 1987.
9. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 270(9), 4650-4660, 1995.
10. TAYLOR, F.B., JR., CHANG, A., RUF, W., MORRISSEY, J.H., HINSHAW, L. and CATLETT, R. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33(3), 127-134, 1991.
11. AUGER, M.J. and MACKIE, M.J. Monocyte procoagulant activity in breast cancer. Thromb Res 47(1), 77-84, 1987.
12. GRIMSTAD, I.A. and PRYDZ, H. Thromboplastin release, but not content, correlates with spontaneous metastasis of cancer cells. Int J Cancer 41, 427-431, 1988.
13. RAO, L.V. Tissue factor as a tumor procoagulant [Review]. Cancer Metastasis Rev 11(3-4), 249-266, 1992.
14. COLE, E.H., SCHULMAN, J., UROWITZ, M., KEYSTONE, E., WILLIAMS, C. and LEVY, G.A. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J Clin Invest 75(3), 861-868, 1985.
15. BLAKELY, M.L., VAN DER WERF, W.J., BERNDT, M.C., DALMASSO, A.P., BACH, F.H. and HANCOCK, W.W. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58(10), 1059-1066, 1994.
16. WILCOX, J.N., SMITH, K.M., SCHWARTZ, S.M. and GORDON, D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86(8), 2839-2843, 1989.
17. NEMERSON, Y. Tissue factor: Then and now. Thromb Haemost 74(1), 180-184, 1995.
18. ESMON, C.T. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 254, 964-973, 1979.
19. EATON, D., RODRIGUEZ, H. and VEHAR, G.A. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25, 505-512, 1986.
20. NAITO, K. and FUJIKAWA, K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266(12), 7353-7558, 1991.
21. GAILANI, D. and BROZE, G.J., JR. Factor XII-independent activation of factor XI in plasma: Effects of sulfatides on tissue factor-induced coagulation. Blood 82(3), 813-819, 1993.
22. ASTRUP, T. Assay and content of tissue thromboplastin in different organs. Thromb Diath Haemorrh 14(3-4), 401-416, 1965.
23. DRAKE. T.A., MORRISSEY, J.H. and EDGINGTON, T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5), 1087-1097, 1989.
24. FAULK, W.P., LABARRERE, C.A. and CARSON, S.D. Tissue factor: Identification and characterization of cell types in human placentae. Blood 76(1), 86-96, 1990.
25. FLECK, R.A., RAO, L.V., RAPAPORT, S.I. and VARKI, N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59(2), 421-437, 1990.
26. FLÖSSEL, C., LUTHER, T., MULLER, M., ALBRECHT, S. and KASPER, M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 101(6), 449-453, 1994.
27. DEL ZOPPO, G.J., YU, J.Q., COPELAND, B.R., THOMAS, W.S., SCHNEIDERMAN, J. and MORRISSEY, J.H. Tissue factor localization in nonhuman primate cerebral tissue. Thromb Haemost 68(6), 642-647, 1992.
28. EDDLESTON, M., DE LA TORRE, J.C., OLDSTONE, M.B., LOSKUTOFF, D.J., EDGINGTON, T.S. and MACKMAN, N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest 92(1), 349-358, 1993.
29. LOCKWOOD, C.J., NEMERSON, Y., GULLER, S., KRIKUN, G., ALVAREZ, M., HAUSKNECHT, V., GURPIDE, E. and SCHATZ, F. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab 76(1), 231-236, 1993.
30. QUIRK, S.M., PENTECOST, B.T., MACKMAN, N., LOSKUTOFF, D.J., HARZELL, S. and HENRIKSON, K.P. The regulation of uterine tissue factor by estrogen. Endocrine 3, 177-184, 1995.
31. MORRISSEY, J.H., FAKHRAI, H. and EDGINGTON, T.S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 50(1), 129-135, 1987.
32. BAZAN, J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87(18), 6934-6938, 1990.
33. HARLOS, K., MARTIN, D.M., O'BRIEN, D.P., JONES, E.Y., STUART, D.I., POLIKARPOV, I., MILLER, A., TUDDENHAM, E.G. and BOYS, C.W. Crystal structure of the extracellular region of human tissue factor. Nature 370(6491), 662-666, 1994.
34. MULLER, Y.A., ULTSCH, M.H., KELLEY, R.F. and DE VOS, A.M. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry 33(36), 10864-10870, 1994.
35. RUF, W., REHEMTULLA, A. and EDGINGTON, T.S. Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J 278, 729-733, 1991.
36. RUF, W. and EDGINGTON, T.S. Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa. Proc Natl Acad Sci USA 88(19), 8430-8434, 1991.
37. O'BRIEN, D.P., ANDERSON, J.S., MARTIN, D.M., BYFIELD, P.G. and TUDDENHAM, E.G. Structural requirements for the interaction between tissue factor and factor VII: Characterization of chymotrypsin-derived tissue factor polypeptides. Biochem J 292, 7-12, 1993.
38. RUF, W., SCHULLEK, J.R., STONE, M.J. and EDGINGTON, T.S. Mutational mapping of functional residues in tissue factor: Identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 33(6), 1565-1572, 1994.
39. GIBBS, C.S., MC CURDY, S.N., LEUNG, L.L. and PABORSKY, L.R. Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistry 33(47), 14003-14010, 1994.
40. SCHULLEK, J.R., RUF, W. and EDGINGTON, T.S. Key ligand interface residues in tissue factor contribute independently to factor VIIa binding. J Biol Chem 269(30), 19399-19403, 1994.
41. RUF, W. and EDGINGTON, T.S. Structural biology of tissue factor, the initiator of thrombogenesis in vivo [Review]. FASEB J 8(6), 385-90, 1994.
42. MARTIN, D.M., BOYS, C.W. and RUF, W. Tissue factor: Molecular recognition and cofactor function [Review]. FASEB J 9(10), 852-859, 1995.
43. BANNER, D.W., D'ARCY, A., CHÈNE, C., VILBOIS, F., KONINGSBERG, W.H., GUHA, A., NEMERSON, Y. and KIRCHHOFER, D. The crystal structure of the complex of human factor VIIa with human soluble tissue factor. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1084), 1995.
44. BACH, R., GENTRY, R. and NEMERSON, Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 25(14), 4007-4020, 1986.
45. SABHARWAL, A.K., BIRKTOFT, J.J., GORKA, J., WILDGOOSE, P., PETERSEN, L.C. and BAJAJ, S.P. High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity. J Biol Chem 270(26), 15523-15530, 1995.
46. RUF, W., REHEMTULLA, A., MORRISSEY, J.H. and EDGINGTON, T.S. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 266(24), 16256, 1991.
47. BROZE, G.J., JR. and MAJERUS, P.W. Purification and properties of human coagulation factor VII. J Biol Chem 255(4), 1242-1247, 1980.
48. BAJAJ, S.P., RAPAPORT, S.I. and BROWN, S.F. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 256(1), 253-259, 1981.
49. DAVIE, E.W., FUJIKAWA, K. and KISIEL, W. The coagulation cascade: Initiation, maintenance, and regulation [Review]. Biochemistry 30(43), 10363-10370, 1991.
50. NEUENSCHWANDER, P.F. and MORRISSEY, J.H. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem 267(20), 14477-14482, 1992.
51. NEUENSCHWANDER, P.F., FIORE, M.M. and MORRISSEY, J.H. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem 268(29), 21489-21492, 1993.
52. HIGASHI, S., NISHIMURA, H., FUJII, S., TAKADA, K. and IWANAGA, S. Tissue factor potentiates the factor VIIa-catalyzed hydrolysis of an ester substrate. J Biol Chem 267(25), 17990-17996, 1992.
53. LAWSON, J.H., BUTENAS, S. and MANN, K.G. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem 267(7), 4834-4843, 1992.
54. RUF, W., KALNIK, M.W., LUND-HANSEN, T. and EDGINGTON, T.S. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 266(24), 15719-15725, 1991.
55. FIORE, M.M., NEUENSCHWANDER, P.F. and MORRISSEY, J.H. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates. Blood 80(12), 3127-3134, 1992.
56. MIYATA, T., FUNATSU A. and KATO, H. Chemical cross-linking of activated coagulation factor VII with soluble tissue factor: Calcium ions are not essential for full amidolytic activity of the factor VIIa-tissue factor complex after complex formation. J Biochem 117, 836-844, 1995.
57. KRISHNASWAMY, S., FIELD, K.A., EDGINGTON, T.S., MORRISSEY, J.H. and MANN, K.G. Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 267(36), 26110-2620, 1992.
58. FIORE, M.M., NEUENSCHWANDER, P.F. and MORRISSEY, J.H. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem 269(1), 143-149, 1994.
59. JANSON, T.L., STORMORKEN, H. and PRYDZ, H. Species specificity of tissue thromboplastin. Haemostasis 14(5), 440-444, 1984.
60. ZIONCHECK, T.F., ROY, S. and VEHAR, G.A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 267(6), 3561-3564, 1992
61. PABORSKY, L.R., CARAS, I.W., FISHER, K.L. and GORMAN, C.M. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 266(32), 21911-21916, 1991.
62. PABORSKY, I.R. and HARRIS, R.J. Posttranslational modifications of recombinant human tissue factor. Thromb Res 60(5), 367-376, 1990.
63. PABORSKY, L.R., FENDLY, B.M., FISHER, K.L., LAWN, R.M., MARKS, B.J., MC CRAY, G., TATE, K.M., VEHAR, G.A. and GORMAN, C.M. Mammalian cell transient expression of tissue factor for the production of antigen. Protein Eng 3(6), 7-53, 1990.
64. RICKLES, F.R., HAIR, G.A., ZEFF, R.A., LEE, E. and BONA, R.D. Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 74(1), 391-395, 1995.
65. BACH, R., KONIGSBERG, W.H. and NEMERSON, Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry 27(12), 4227-4231, 1988.
66. ALVAREZ, E., GIRONES, N. and DAVIS, R.J. Inhibition of the receptor-mediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic. J Biol Chem 265(27), 16644-16655, 1990.
67. KAWATE, N. and MENON, K.M. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. Abolition of palmitoylation by mutation of Cys-621 and Cys-622 residues in the cytoplasmic tail increases ligand-induced internalization of the receptor. J Biol Chem 269(48), 30651-30658, 1994.
68. ROY, S., PABORSKY, L.R. and VEHAR, G.A. Self-association of tissue factor as revealed by chemical crosslinking. J Biol Chem 266(8), 4665-4668, 1991.
69. REHEMTULLA, A., RUF, W. and EDGINGTON, T.S. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem 266(16), 10294-10299, 1991.
70. LYBERG, T., GALDAL, K.S., EVENSEN, S.A. and PRYDZ, H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 53(1), 85-95, 1983.
71. JOHNSEN, U.L, LYBERG, T., GALDAL, K.S. and PRYDZ, H. Platelets stimulate thromboplastin synthesis in human endothelial cells. Thromb Haemost 49(2), 69-72, 1983.
72. NIEMETZ, J. and MARCUS, A.J. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 54(6), 1437-1443, 1974.
73. LO, S.K., CHEUNG, A., ZHENG, Q. and SILVERSTEIN, R.L. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 154(9), 4768-4777, 1995.
74. CELI, A., PELLEGRINI, G., LORENZET, R., DE BLASI, A., READY, N., FURIE, B.C. and FURIE, B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91(19), 8767-8771, 1994.
75. FAN, S.T. and EDGINGTON, T.S. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest 87(1), 50-57, 1991.
76. FAN, S.T., MACKMAN, N., CUI, M.-Z. and EDGINGTON, T.S. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J Immunol 154(7), 3266-3274, 1995.
77. HARTZELL, S., RYDER, K., LANAHAN, A., LAU, L.F. and NATHAN, D. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 9(6), 2567-2573, 1989.
78. BLOEM, L.J., CHEN L., KONIGSBERG, W.H. and BACH, R. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol 139(2), 418-423, 1989.
79. 2+ mobilization and protein kinase C activation. J Clin Invest 91(2), 547-552, 1993.
80. PETTERSEN, K.S., WIIGER, M.T., NARAHARA, N., ANDOH, K., GAUDERNACK, G. and PRYDZ, H. Induction of tissue factor synthesis in human umbilical vein endothelial cells involves protein kinase C. Thromb Haemost 67(4), 473-477, 1992.
81. KUCEY, D.S., CHEUNG, P.Y. and ROTSTEIN, O.D. Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism. Infect Immun 60(3), 944-950, 1992.
82. TERNISIEN, C., RAMANI, M., OLLIVIER, V., KHECHAI, F., VU, T., HAKIM, J., and DE PROST, D. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost 70(5), 800-806, 1993.
83. FAUCETTE, K.J., FITZGERALD, L.A., LIU, L., PARKER, C.J. and RODGERS, G.M. Characterization of the interactions between procoagulant albumin and human endothelial cells. Blood 82(9), 2684-2692, 1993.
84. HERBERT, J.M., SAVI, P., LAPLACE, M.C., DUMAS, A. and DOL, F. Chelerythrine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin downregulation in endothelial cells. Thromb Res 71(6), 487-493, 1993.
85. YANG, Z., BOCHSLER, P.N., CARROLL, R.C., CARTER, C.D., KHEMLANI, L.S. and BREIDER, M.A. Signal transduction pathways of bacterial lipopolysaccharide-stimulated bovine vascular endothelial cells. Inflammation 18(2), 221-233, 1994.
86. YANG, H.L., LU, F.J., WUNG, S.L. and CHIU, H.C. Humic acid induces expression of tissue factor by cultured endothelial cells: Regulation by cytosolic calcium and protein kinase C. Thromb Haemost 71(3), 325-330, 1994.
87. PODEVIN, P., CALMUS, Y., ROBERT, A., POUPON, R. and CHERQUI, G. Inhibition of procoagulant activity of human monocytes by chenodeoxycholic acid: Involvement of protein kinase C. Hepatology 19(5), 1164-1170, 1994.
88. VAN DER LOGT, C.P., DIRVEN, R.J., REITSMA, P.H. and BERTINA, R.M. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul Fibrinol 5(2), 211-220, 1994.
89. CUI, M.Z., PARRY, G.C., EDGINGTON, T.S. and MACKMAN, N. Regulation of tissue factor gene expression in epithelial cells. Induction by serum and phorbol 12-myristate 13-acetate. Arterioscler Thromb 14(5), 807-814, 1994.
90. LYBERG, T. Effect of cyclic AMP and cyclic GMP on thromboplastin (factor III) synthesis in human monocytes in vitro. Thromb Haemost 50(4), 804-809, 1983.
91. HASDAY, J.D. and SITRIN, R.G. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: A possible mechanism of antithrombotic action. Blood 69(2), 660-667, 1987.
92. 2-release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide. Thromb Res 60(2), 141-156, 1990.
93. DE PROST, D., OLLIVIER, V. and HAKIM, J. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes. Mol Pharmacol 38(4), 562-566, 1990.
94. CRUTCHLEY, D.J. and HIRSH, M.J. The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro. Blood 78(2), 382-386, 1991.
95. OLLIVIER, V., HOUSSAYE, S., TERNISIEN, C., LEON, A., DE VERNEUIL, H., ELBIM, C., MACKMAN, N., EDGINGTON, T.S. and DE PROST, D. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 81(4), 973-979, 1993.
96. OLLIVIER, V., TERNISIEN, C., VU, T., HAKIM, J. and DE PROST, D. Pentoxifylline inhibits the expression of tissue factor mRNA in endotoxin-activated human monocytes. FEBS Lett 322(3), 231-234, 1993.
97. ARCHIPOFF, G., BERETZ, A., BARTHA, K., BRISSON, C., DE LA SALLE, C. FROGET-LEON, C., KLEIN-SOYER, C. and CAZENAVE, J.P. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities. Br J Pharmacol 109(1), 18-28, 1993.
98. RAMANI, M., KHECHAI, F., OLLIVIER, V., TERNISIEN, C., BRIDEY, F., HAKIM, J. and DE PROST, D. Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes. FEBS Lett 356(1), 86-88, 1994.
99. PRYDZ, H. and LYBERG, T. Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharmacol 29(1), 9-14, 1980.
100. CROSSMAN, D.C., CARR, D.P., TUDDENHAM, E.G., PEARSON, J.D. and MC VEY, J.H. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265(17), 9782-9787, 1990.
101. BUSSO, N., HUET, S., NICODEME, E., HIERNAUX, J. and HYAFIL, F. Refractory period phenomenon in the induction of tissue factor expression on endothelial cells. Blood 78(8), 2027-2035, 1991.
102. MISEREZ, R. and JUNGI, T.W. LPS-induced, but not interferon-gamma-induced procoagulant activity of suspended human macrophages is followed by a refractory state of low procoagulant expression. Thromb Res 65(6), 733-744, 1992.
103. GREGORY, S.A., MORRISSEY, J.H. and EDGINGTON, T.S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9(6), 2752-2755, 1989.
104. BRAND, K., FOWLER, B.J., EDGINGTON, T.S. and MACKMAN, N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol 11(9), 4732-4738, 1991.
105. AHERN, S.M., MIYATA, T. and SADLER, J.E. Regulation of human tissue factor expression by mRNA turnover. J Biol Chem 268(3), 2154-2159, 1993.
106. BACH, R. and RIFKIN, D.B. Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87(18), 6995-6999, 1990.
107. CARSON, S.D., PERRY, G.A. and PIRRUCCELLO, S.J. Fibroblast tissue factor: Calcium and ionophore induce shape changes, release of membrane vesicles, and redistribution of tissue factor antigen in addition to increased procoagulant activity. Blood 84(2), 526-534, 1994.
108. HERBERT, J.M., SAVI, P., LAPLACE, M.C. and LALE, A. IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 310(1), 31-33, 1992.
109. HERBERT, J.M., SAVI, P., LAPLACE, M.C., LALE, A., DOL, F., DUMAS, A., LABIT, C., and MINTY, A. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328(3), 268-270, 1993.
110. MARTIN, N.B., JAMIESON, A. and TUFFIN, D.P. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Thromb Haemost 70(6), 1037-1042, 1993.
111. PRADIER, O., GERARD, C., DELVAUX, A., LYBIN, M., ABRAMOWICZ, D., CAPEL, P., VELU, T. and GOLDMAN, M. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23(10), 2700-2703, 1993.
112. RAMANI, M., OLLIVIER, V., KHECHAI, F., VU, T., TERNISIEN, C., BRIDEY, F. and DE PROST, D. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett 334(1), 114-116, 1993.
113. RAMANI, M., OLLIVIER, V., TERNISIEN, C., VU, T., ELBIM, C., HAKIM, J. and DE PROST, D. Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation. Br J Haematol 85(3), 462-468, 1993.
114. ISHII, H., HORIE, S., KIZAKI, K. and KAZAMA, M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 50(10), 2556-2562, 1992.
115. BARSTAD, R.M., HAMERS, M.J., STEPHENS, R.W. and SAKARIASSEN, K.S. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation. Blood 86(1), 212-218, 1995.
116. MC GEE, M.P., FOSTER, S. and WANG, X. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation. J Exp Med 179(6), 1847-1854, 1994.
117. BEVILACQUA, M.P., POBER, J.S., WHEELER, M.E., COTRAN, R.S. and GIMBRONE M.A., JR. Interleukin 1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 121, 393-403, 1985.
118. BEVILACQUA, M.P., POBER, J.S., MENDRICK, D.L., COTRAN, R.S. and GIMBRONE, M.A., JR. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84, 9238-9242, 1987.
119. CARLOS, T.M., SCHWARTZ, B.R., KOVACH, N.L., YEE, E., ROSA, M., OSBORN, L., CHI-ROSSO, G., NEWMAN, B., LOBB, R. and ROSA, M. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 76, 965-970, 1990.
120. SCHLEEF, R.S., LOSKUTOFF, D.J. and PODOR, T.J. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. J Cell Biol 113, 1413-1423, 1991.
121. NAWROTH, P.P., HANDLEY, D.A., ESMON, C.T. and STERN, D.M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83, 3460-3464, 1986.
122. MOORE, K.L., ANDREOLI, S.P., ESMON, N.L., ESMON, C.T. and BANG, N.U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79, 124-130, 1987.
123. MOORE, K.L., ESMON, C.T. and ESMON, N.L. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73, 159-165, 1989.
124. BARTHA, K., BRISSON, C., ARCHIPOFF, G., DE LA SALLE, C., LANZA, F., CAZENAVE, J.P. and BERETZ, A. Thrombin regulates tissue factor and thrombo-modulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem 268(1), 421-429, 1993.
125. SCHLEEF, R.S., BEVILACQUA, M.P., SAWDEY, M., GIMBRONE, M.A., JR. and LOSKUTOFF, D.J. Cytokine activation of vascular endothelium. J Biol Chem 263, 5797-5803, 1988.
126. KIRCHHOFER, D., TSCHOPP, T.B., HADVARY, P. and BAUMGARTNER, H.R. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 93(5), 2073-2083, 1994.
127. MACKMAN, N. Regulation of the tissue factor gene [Review]. FASEB J 9(10), 883-889, 1995.
128. FISHER, K.L., GORMAN, C.M., VEHAR, G.A., O'BRIEN, D.P. and LAWN, R.M. Cloning and expression of human tissue factor cDNA. Thromb Res 48(1), 89-99, 1987.
129. SCARPATI, E.M., WEN, D., BROZE, G.J., JR., MILETICH, J.P., FLANDERMEYER, R.R., SIEGEL, N.R. and SADLER, J.E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26(17), 5234-5238, 1987.
130. SPICER, E.K., HORTON, R., BLOEM, L., BACH, R., WILLIAMS, K.R., GUHA, A., KRAUS, J., LIN, T.C., NEMERSON, Y. and KONIGSBERG, W.H. Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA. Proc Natl Acad Sci USA 84(15), 5148-5152, 1987.
131. RANGANATHAN, G., BLATTI, S.P., SUBRAMANIAM, M., FASS, D.N., MAIHLE, N.J. and GETZ, M.J. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type beta 1. J Biol Chem 266(1), 496-501, 1991.
132. ANDREWS, B.S., REHEMTULLA, A., FOWLER, B.J., EDGINGTON, T.S. and MACKMAN, N. Conservation of tissue factor primary sequence among three mammalian species. Gene 98(2), 265-269, 1991.
133. PAWASHE, A., EZEKOWITZ, M., LIN, T.C., HORTON, R., BACH, R. and KONIGSBERG, W. Molecular cloning, characterization and expression of cDNA for rabbit brain tissue factor. Thromb Haemost 66(3), 315-320, 1991.
134. TAKAYENOKI, Y., MUTA, T., MIYATA, T. and IWANAGA, S. cDNA and amino acid sequences of bovine tissue factor. Biochem Biophys Res Commun 181(3), 1145-1150, 1991.
135. MACKMAN, N., MORRISSEY, J.H., FOWLER, B. and EDGINGTON, T.S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 28(4), 1755-1762, 1989.
136. MACKMAN, N., IMES, S., MASKE, W.H., TAYLOR, B., LUSIS, A.J. and DRAKE, T.A. Structure of the murine tissue factor gene. Chromosome location and conservation of regulatory elements in the promoter. Arterioscler Thromb 12(4), 474-83, 1992.
137. SCARPATI, E.M., SADLER, J.E., O'CONNELL, P., NAKAMURA, Y., LEPPERT, M., BALLARD, L., LATHROP, G.M. and LALOUEL, J.M. White Identification and mapping of RFLPs for human tissue factor (HTF) to chromosome 1p. Nucleic Acids Res 15(21), 9098, 1987.
138. MOLL, T., CZYZ, M., HOLZMULLER, H., HOFER-WARBINEK, R., WAGNER, E., WINKLER, H., BACH, F.H. and HOFER, E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem 270(8), 3849-3857, 1995.
139. MACKMAN, N., FOWLER, B.J., EDGINGTON, T.S. and MORRISSEY, J.H. Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci USA 87(6), 2254-2258, 1990.
140. NATHWANI, A.C., GALE, K.M., PEMBERTON, K.D., CROSSMAN, D.C., TUDDENHAM, E.G. and MC VEY, J.H. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene. Br J Haematol 88(1), 122-128, 1994.
141. BIERHAUS, A., SERNAU, T., QUEHENBERGER, P., MACKMAN, N., HAASE, M., LUTHER, T., KASPER, M., WAHL, P., STERN, D.M., MULLER, M. and NAWROTH, P.P. A newly identified NF-κB-like site in the tissue factor promoter is involved in advanced glycosylation end products (AGEs) mediatiated induction of tissue factor. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1093), 1995.
142. TREISMAN, R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46(4), 567-574, 1986.
143. MADDEN, S.L. and RAUSCHER, F.J., III. Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc-finger gene products [Review]. Ann NY Acad Sci 684, 75-84, 1993.
144. TERNISIEN, C., OLLIVIER, V., KHECHAI, F., RAMANI, M., HAKIM, J. and de PROST, D. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes. Thromb Haemost 73(3), 413-420, 1995.
145. WEINSTEIN, S.L., SANGHERA, J.S., LEMKE, K., DE FRANCO, A.L. and PELECH, S.L. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases. J Biol Chem 267(21), 14955-14962, 1992.
146. DONG, Z., QI, X. and FIDLER, I.J. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J Exp Med 177(4), 1071-1077, 1993.
147. STEINEMANN, S., ULEVITCH, R. J. and MACKMAN, N. Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb 14(7), 1202-1209, 1994.
148. READ, M.A., CORDLE, S.R., VEACH, R.A., CARLISLE, C.D. and HAWIGER, J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 90(21), 9887-9891, 1993.
149. MESZAROS, K., ABERLE, S., DEDRICK, R., MACHOVICH, R., HORWITZ, A., BIRR, C., THEOFAN, G. and PARENT, J.B. Monocyte tissue factor induction by lipopolysaccharide (LPS): Dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. Blood 83(9), 2516-2525, 1994.
150. WRIGHT, S.D., RAMOS, R.A., TOBIAS, P.S., ULEVITCH, R.J. and MATHISON, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249(4975), 1431-1433, 1990.
151. WRIGHT, S.D. and JONG, M.T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med 164(6), 1876-1888, 1986.
152. BRIGHT, S.W., CHEN, T.Y., FLEBBE, L.M., LEI, M.G. and MORRISON, D.C. Generation and characterization of hamster-mouse hybridomas secreting monoclonal antibodies with specificity for lipopolysaccharide receptor. J Immunol 145(1), 1-7, 1990.
153. LIN, T.H., YUROCHKO, A., KORNBERG, L., MORRIS, J., WALKER, J.J., HASKILL, S. and JULIANO, R.L. The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes. J Cell Biol 126(6), 1585-1593, 1994.
154. MACKMAN, N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem 269(42), 26363-26367, 1994.
155. ORTHNER, C.L., RODGERS, G.M. and FITZGERALD, L.A. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: Evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 86(2), 436-443, 1995.
156. WEBER, C., ERL, W., PIETSCH, A. and WEBER, PC. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91(1), 1914-1917, 1995.
157. + channel blockers inhibit tissue factor expression by human monocytic cells. Circ Res 76(1), 16-20, 1995.
158. MACKMAN, N., BRAND, K. and EDGINGTON, T.S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 174(6), 1517-1526, 1991.
159. DONOVAN-PELUSO, M., GEORGE, L.D. and HASSETT, A.C. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells. Protein-DNA interactions with the promoter. J Biol Chem 269(2), 1361-1369, 1994.
160. PARRY, G.C. and MACKMAN, N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Biol 15(5), 612-621, 1995.
161. PARRY, G.C. and MACKMAN, N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 269(33), 20823-20825, 1994.
162. OETH, P.A., PARRY, G.C., KUNSCH, C., NANTERMET, P., ROSEN, C.A. and MACKMAN, N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol 14(6), 3772-3781, 1994.
163. BIERHAUS, A., HEMMER, C.J., MACKMAN, N., KUTOB, R., ZIEGLER, R., DIETRICH, M. and NAWROTH, P.P. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation. Thromb Haemost 73(1), 39-48, 1995.
164. SCARPATI, E.M. and SADLER, J.E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264(34), 20705-20713, 1989.
165. HETLAND, O., BROVOLD, A.B., HOLME, R., GAUDERNACK, G. and PRYDZ, H. Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J 228(3), 735-743, 1985.
166. DRAKE, T.A., RUF, W., MORRISSEY, J.H. and EDGINGTON, T.S. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 109(1), 389-395, 1989.
167. CARSON, S.D., PIRRUCCELLO, S.J. and HAIRE, W.D. Tissue factor antigen and activity are not expressed on the surface of intact cells isolated from an acute promyelocytic leukemia patient. Thromb Res 59(1), 159-170, 1990.
168. RYAN, J., BRETT, J., TIJBURG, P., BACH, R.R., KISIEL, W. and STERN, D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80(4), 966-974, 1992.
169. NARAHARA, N., ENDEN, T., WIIGER, M., PRYDZ, H. Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb 14(11), 1815-1820, 1994.
170. MULDER, A.B., HEGGE-PAPING, K.S., MAGIELSE, C.P., BLOM, N.R., SMIT, J.W., VAN DER MEER, J., HALLIE, M.R. and BOM, V.J. Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood 84(5), 1559-1566, 1994.
171. LE, D.T., RAPAPORT, S.I. and RAO, L.V. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 267(22), 15447-15454, 1992.
172. RAO, L.V., ROBINSON, T. and HOANG, A.D. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: A kinetic study. Thromb Haemost 67(6), 654-659, 1992.
173. BJØRKLID, E. and STORM, E. Purification and some properties of the protein component of tissue thromboplastin from human brain. Biochem J 165(1), 89-96, 1977.
174. RAVANAT, C., ARCHIPOFF, G., BERETZ, A., FREUND, G., CAZENAVE, J.P. and FREYSSINET, J.M. Use of annexin-V to demonstrate the role of phosphatidyl-serine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J 282, 7-13, 1992.
175. BROZNA, J.P., FORMAN, M. and CARSON, S.D. Staurosporine blocks downregulation of monocyte-associated tissue factor. Blood Coagul Fibrinol 5(6), 929-938, 1994.
176. HJORT, P.F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand J Clin Lab Invest 9(Suppl. 27), 1-183, 1957.
177. SANDSET, P.M., ABILDGAARD, U. and PETTERSEN, M. A sensitive chromogenic substrate assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 47, 389-400, 1987.
178. BROZE, G.J., JR., WARREN, L.A., NOVOTNY, W.F., HIGUCHI, D.A., GIRARD, J. J. and MILETICH, J.P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71(2), 335-343, 1988.
179. BOHN, H. and WINCKLER, W. Isolation and characterization of the placental protein pp5 (author's transl) [German]. Arch Gynakol 223(3), 179-186, 1977.
180. SPRECHER, C.A., KISIEL, W., MATHEWES, S. and FOSTER, D.C. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA 91(8), 3353-3357, 1994.
181. MIYAGI, Y., KOSHIKAWA, N., YASUMITSU, H. MIYAGI, E., HIRAHARA, F., AOKI, I., MISUGI, K., UMEDA, M. and MIYAZAKI, K. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: Identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem (Tokyo) 116(5), 939-942, 1994.
182. KONDO, S., NOGUSHI, M., FUNAKOSHI, T., FUJIKAWA, K. and KISIEL, W. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Thromb Res 48(4), 449-459, 1987.
183. ABILDGAARD, U. Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis. Scand J Clin Lab Invest 21(1), 89-91, 1968.
184. RAO, L.V., RAPAPORT, S.I. and HOANG, A.D. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 81(10), 2600-2607, 1993.
185. CONKLING, P.R., PATTON, K.L., HANNUN, Y.A., GREENBERG, C.S. and WEINBERG, J.B. Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding. J Biol Chem 264(31), 18440-188444, 1989.
186. SLUNGAARD, A., NESLESTUEN, G.L. and KEY, N.S. Platelet factor 4 (PF4) binds to the γ-carboxyglutamic acid (GLA) domain of plasma clotting factors and impairs tissue factor (TF)-mediated coagulation. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1089), 1995.
187. CALLANDER, N.S., RAO, L.V., NORDFANG, O., SANDSET, P.M., WARNCRAMER, B. and RAPAPORT, S.I. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem 267(2), 876-882, 1992.
188. ALMUS, F.E., RAO, L.V. and RAPAPORT, S.I. Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model. Arterioscler Thromb 13(1), 105-111, 1993.
189. LINDHOUT, T., BLEZER, R., SCHOEN, P., NORDFANG, O., REUTELINGSPERGER, C. and HEMKER, H.C. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood 79(11), 2909-2016, 1992.
190. VAN'T VEER, C., HACKENG, T.M., DELAHAYE, C., SIXMA, J.J. and BOUMA, B.N. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: Effect of the tissue factor pathway inhibitor. Blood 84(4), 1132-1142, 1994.
191. SANDSET, P.M., WARN-CRAMER, B.J., MAKI, S.L. and RAPAPORT, S.I. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood 78(6), 1496-1502, 1991.
192. SANDSET, P.M., WARN-CRAMER, B.J., RAO, L.V., MAKI, S.L. and RAPAPORT, S.I. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiological role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 88(3), 708-712, 1991.
193. BREGENGARD, C., NORDFANG, O., WILDGOOSE, P., SVENDSEN, O., HEDNER, U. and DINESS, V. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Blood Coagul Fibrinol 4(5), 699-706, 1993.
194. CREASEY, A.A., CHANG, A.C., FEIGEN, L., WUN, T.C., TAYLOR, F.B., JR. and HINSHAW, L.B. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91(6), 2850-2856, 1993.
195. HASKEL, E.J., TORR, S.R., DAY, K.C., PALMIER, M.O., WUN, T.C., SOBEL, B.E. and ABENDSCHEIN, D.R. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation 84(2), 821-827, 1991.
196. OLTRONA, L., SPEIDEL, C.M., RECCHIA, D. and ABENDSHEIN, D.R. Inhibition of tissue factor-mediated thrombosis markedly attenuates stenosis after balloon-induced arterial injury in hyperlipidemic minipigs. Circulation 90, I-334 (abstract), 1994.
197. HOLST, J., LINDBLAD, B., BERGQVIST, D., NORDFANG, O., OSTERGAARD, P.B., PETERSEN, J.G., NIELSEN, G. and HEDNER, U. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosi - A comparison with low molecular weight heparin. Thromb Haemost 71(2), 214-219, 1994.
198. KHOURI, R.K., KOUDSI, B., KAIDING, F., ORNBERG, R.L. and WUN, T.C. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 30(5), 398-402; discussion 402-404, 1993.
199. KHOURI, R.K., KOUDSI, B., KAIDING, F., ORNBERG, R.L. and WUN, T.C. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 30(5), 398-402; discussion 402-404, 1993.
200. LINDAHL, A.K., ABILDGAARD, U., LARSEN M.L., AAMODT, L.M., NORDFANG, O. and BECK, T.C. Extrinsic pathway inhibitor (EPI) and the postheparin anti-coagulant effect in tissue thromboplastin induced coagulation. Thromb Res Suppl 14, 39-48, 1991.
201. VALENTIN, S., OSTERGAARD, P., KRISTENSEN, H. and NORDFANG, O. Synergism between full length TFPI and heparin: Evidence for TFPI as an important factor for the antithrombotic activity of heparin (letter). Blood Coagul Fibrinol 3(2), 221-222, 1992.
202. OSTERGAARD, P., NORDFANG, O., PETERSEN, L.C., VALENTIN, S. and KRISTENSEN, H. Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins? Biochemical considerations (review). Haemostasis 23(Suppl 1), 102-111, 1993.
203. HOLST, J., LINDBLAD, B., WEDEBERG, E., BERGQUIST, D., NORDFANG, O., ØSTERGAARD, P.B. and HEDNER, U. Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis. Thromb Res 72(5), 467-470, 1993.
204. KIJOWSKI, R., HOPPENSTEADT, D., WALENGA, J., BORRIS, L., LASSEN, M.R. and FAREED, J. Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin. Thromb Res 74(1), 53-64, 1994.
205. RAO, L.V., NORDFANG, O., HOANG, A.D. and PENDURTHI, U.R. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 85(1), 121-129, 1995.
206. JESKE, W., HOPPENSTEADT, D., KLAUSER, R., KAMMEREIT, A., ECKENBERGER, P., HAAS, S., WYLD, P. and FAREED, J. Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels. Blood Coagul Fibrinol 6(2), 119-124, 1995.
207. ØSTERUD, B., BAJAJ, M.S. and BAJAJ, S.P. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiological and pathologic conditions. Thromb Haemost 73(5), 873-875, 1995.
208. BAJAJ, M.S., KUPPUSWAMY, M.N., LEINGANG, K. and BAJAJ, S.P. Transcriptional expression of tissue factor pathway inhibitor in normal human tissues. Blood 82(Suppl 11), (abstract 1071), 1993.
209. ISHII, H., SALEM, H.H., BELL, C.E., LAPOSATA, E.A. and MAJERUS, P.W. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood 67(2), 362-365, 1986.
210. VAN NOSTRAND, W.E., SCHMAIER, A.H. and WAGNER, S.L. Potential role of protease nexin-2/amyloid beta-protein precursor as a cerebral anticoagulant [Review]. Ann NY Acad Sci 674, 243-252, 1992.
211. AMERI, A., KUPPUSWAMY, M.N., BASU, S. and BAJAJ, S.P. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 79(12), 3219-3226, 1992.
212. NORDFANG, O., VALENTIN, S., BECK, T.C. and HEDNER, U. Inhibition of extrinsic pathway shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost 66(4), 464-467, 1991.
213. ERHARDTSEN, E., MADSEN, M.T., EZBAN, M., HEDNER, U., DINESS, V., GLAZER, S. and NORDFANG, O. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced hemophelia A. Thromb Haemost 69, 556 (abstract 54), 1993.
214. WILCOX, J.N., HASKO, J.A., DEISHER, T.A. and BUNTING, S. Identification of cells expressing tissue factor mRNA by in situ hybridization after in vivo administration of endotoxin to rats. Thromb Haemost 62, 348 (abstract 1084), 1989.
215. SOLBERG, S., ØSTERUD, B., LARSEN, T. and SORLIE, D. Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins. Blood Coagul Fibrinol 1(6), 595-600, 1990.
216. MACKMAN, N., SAWDEY, M.S., KEETON, M.R. and LOSKUTOFF, D.J. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 143(1), 76-84, 1993.
217. DRAKE, T.A., CHENG, J., CHANG, A. and TAYLOR, F.B., JR. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142(5), 1458-1470, 1993.
218. LASZIK, Z., CARSON, C.W., NADASDY, T., JOHNSON, L.D., LERNER, M.R., BRACKETT, D.J., ESMON, C.T. and SILVA, F.G. Lack of suppressed renal thrombomodulin expression in a septic rat model with glomerular thrombotic microangiopathy. Lab Invest 70(6), 862-867, 1994.
219. WEISS, H.J., TURITTO, V.T., BAUMGARTNER, H.R., NEMERSON, Y. and HOFFMANN, T. Evidence for the presence of tissue factor activity on subendothelium. Blood 73(4), 968-975, 1989.
220. SPEIDEL, C.M., EDGINGTON, T.S., EISENBERG, P.R. and ABENDSHEIN, D.R. Tissue factor induces prolonged procoagulant activity on the luminal surface of rabbit aortas after balloon-induced injury. Circulation 90, I-344 (abstract) 1994.
221. DIQUÉLOU, A., DUPOUY, D., GASPIN, D., CONSTANS, J., SIE, P., BONEU, B., SAKARIASSEN, K.S. and CADROY. Y. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost 74(2), 778-783, 1995.
222. ØSTERUD, B. and FLAEGSTAD, T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb Haemost 49(1), 5-7, 1983.
223. KJAEVE, J., ØSTERUD, B. and BJERTNAES, L. The function of granulocytes and alveolar macrophages following a single dose of endotoxin in rabbits. Effects of methylprednisolone. Acta Anaesthesiol Scand 34(8), 619-623, 1990.
224. HANCOCK, W.W., GEE, D., DE MOERLOOSE, P., RICKLES, F.R., EWAN, V.A. and ATKINS, R.C. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation 39(4), 430-438, 1985.
225. EDWARDS, R.L., LEVINE, J.B., GREEN, R., DUFFY, M., MATHEWS, E., BRANDE, W. and RICKLES, F.R. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92(2), 329-337, 1987.
226. EDWARDS, R.L., RICKLES, F.R., and CRONLUND, M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med 98(6), 917-928, 1981.
227. LEATHAM, E.W., BATH, P.M., TOOZE, J.A. and CAMM, A.J. Increased monocyte tissue factor expression in coronary disease. Br Heart J 73(1), 10-13, 1995.
228. KAPPELMAYER, J., BERNABEI, A., EDMUNDS, L.H., JR., EDGINGTON, T.S. and COLMAN, R.W. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 72(5), 1075-1081, 1993.
229. BOISCLAIR, M.D., LANE, D.A., PHILIPPOU, H., ESNOUF, M.P., SHEIKH, S., HUNT, B. and SMITH, K.J. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82(11), 3350-337, 1993.
230. LEVI, M., TEN CATE, H., BAUER, K.A., VAN DER POLL, T., EDGINGTON, T.S., BULLER, H.R. VAN DEVENTER, S.J., HACK, C.E., TEN CATE, J.W. and ROSENBERG, R.D. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93(1), 114-120, 1994.
231. BIEMOND, B.J., LEVI, M., TEN CATE, H., SOULE, H.R., MORRIS, L.D., FOSTER, D.L., BOGOWITZ, C.A., VAN DER POLL, T., BULLER, H.R. and TEN GATE, J.W. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemost 73(2), 223-230, 1995.
232. SAKARIASSEN, K.S., ROALD, H.E., and SALATTI, J.A. Ex vivo models for studying thrombosis: Special emphasis on shear rate dependent blood-collagen interactions. In: Advances in Cardiovascular Engineering. N.H.C. Hwang, V.T. Turritto, and M.R.T. Yen (eds), pp. 151-174, Plenum Press, New York (1992).
233. SLACK, S.M. and TURITTO, V.T. Flow chambers and their standardization for use in studies of thrombosis. Thromb Haemost 72(5), 777-781, 1994.
234. GEMMELL, C.H., BROZE, G.J, JR., TURITTO, V.T. and NEMERSON, Y. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor. Blood 76(11), 2266-2271, 1990.
235. GEMMELL, C.H., NEMERSON, Y. and TURITTO, V. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex. Microvasc Res 40(3), 327-340, 1990.
236. GEMMELL, C.H., TURITTO, V.T. and NEMERSON, Y. Factors affecting the interaction of tissue factor/factor VII with factor X in a heterogeneous tubular reactor. Thromb Haemost 65(2), 139-143, 1991.
237. TIJBURG, P.N., RYAN, J., STERN, D.M., WOLLITZKY, B., RIMON, S., RIMON, A., HANDLEY, D., NAWROTH, P., SIXMA, J.J. and DE GROOT, P.G. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa. J Biol Chem 266(18), 12067-12074, 1991.
238. SALATTI, J.A., ANTON, P., NEMERSON, Y. and SAKARIASSEN, K.S. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly Asp-Val. Experiments with flowing nonanticoagulated human blood. Blood Coagul Fibrinol 4(6), 881-90, 1993.
239. VERHEIJ, M., DEWIT, L.G. and VAN MOURIK, J.A. The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Haemost 73(5), 894-895, 1995.
240. ZWAGINGA, J.J., SIXMA, J.J. and DE GROOT, P.G. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. Arteriosclerosis 10(1), 49-61, 1990.
241. CALLANDER, N.S., VARKI, N. and RAO, L.V. Immunohistochemical identification of tissue factor in solid tumors. Cancer 70(5), 1194-201, 1992.
242. STURM, U., LUTHER, T., ALBRECHT, S., FLOSSEL, C., GROSSMANN, H., and MULLER, M. Immunohistochemical detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Archiv-A. Pathol Anat Histopathol 421(2), 79-86, 1992.
243. ZHANG, V.M., BACHMANN, S., HEMMER, C., VAN LUNZEN, J., VON STEMM, A., KERN, P., DIETRICH, M., ZIEGLER, R., WALDHERR, R. and NAWROTH, P.P. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 144(1), 51-59, 1994.
244. SATO, N., TAKAHASHI, H., KISHI, K., and SHIBATA, A. Synthesis of tissue factor in leukemic cell lines. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1079), 1995.
245. DVORAK, H.F., Van De WATER, L., BITZER, A.M., DVORAK, A.M., ANDERSON, D., HARVEY, V.S., BACH, R., DAVIS, G.L., DE WOLF, W. and CARVAHLO, A.C. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43(9), 4434-4442, 1983.
246. ADAMSON, A.S., FRANCIS, J.L., WITHEROW, R.O. and SNELL, M.E. Urinary tissue factor levels in prostatic carcinoma: A potential marker of metastatic spread? Br J Urol 71(5), 587-592, 1993.
247. KAKKAR, A.K., DE RUVO, N., CHINSWANGWATANAKUL, V., TEBBUTT, S., and WILLIAMSON, R.C.N. Elevated tissue factor and factor VIIa levels indicate selective activation of the extrinsic pathway in human malignancy. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1484), 1995.
248. MUELLER, B.M., REISFELD, R.A., EDGINGTON, T.S. and RUF, W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 89(24), 11832-11836, 1992.
249. BROMBERG, M.E., GAREN, A., and KONINGSBERG, W.H. Increasing expression of tissue factor in human melanoma cells induces metastasis in a murine model. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1060), 1995.
250. ZHANG, Y., DENG, Y., LUTHER, T., MULLER, M., ZIEGLER, R., WALDHERR, R., STERN, D.M. and NAWROTH, P.P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94(3), 1320-1327, 1994.
251. LIJIMA, K., FUKUDA, C. and NAKAMURA, K. Measurements of tissue factor-like activity in plasma of patients with DIC. Thromb Res 61(1), 29-38, 1991.
252. TAKAHASHI, H., SATOH, N., WADA, K., TAKAKUWA, E., SEKI, Y. and SHIBATA, A. Tissue factor in plasma of patients with disseminated intravascular coagulation. Am J Hematol 46(4), 333-337, 1994.
253. WADA, H., NAKASE, T., NAKAYA, R., MINAMIKAWA, K., WAKITA, Y., KANEKO, T., OHIWA, M., DEGUCHI, K. and SHIRAKAWA, S. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 45(3), 232-236, 1994.
254. KOYAMA, T., NISHIDA, K., OHDAMA, S., SAWADA, M., MURAKAMI, N., HIROSAWA, S., KURIYAMA, R., MATSUZAWA, K., HASEGAWA, R. and AOKI, N. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 87(2), 343-347, 1994.
255. BJøRKLID, E., GIERCKSKY, K.E. and PRYDZ, H. An immunoradiometric assay for factor III (tissue thromboplastin). Br J Haematol 39, 445-458, 1978.
256. GIERCKSKY, K.-E., BJØRKLID, E., PRYDZ, H. and RENCK, H. Circulating tissue thromboplastin during hip surgery. Eur Surg Res 11, 296-300, 1979.
257. GORDON, S.G. and CHELLADURAI, M. Nontissue factor procoagulants in cancer cells [Review]. Cancer Metastasis Rev 11(3-4), 267-282, 1992.
258. ALTIERI, D.C. Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion [Review]. Blood 81(3), 569-579, 1993.
259. ALTIERI, D.C. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J Biol Chem 269(5), 3139-3142, 1994.
260. KAZAMA, Y., HAMAMOTO, T., FOSTER, D.C. and KISIEL, W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 270(1), 66-72, 1995.
261. HOFFMAN, M., MONROE, D.M. and ROBERTS, H.R. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: Implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia. Blood 83(1), 38-42, 1994.
262. REUNING, U., PREISSNER, K.T. and MULLER-BERGHAUS, G. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa. Thromb Haemost 69(2), 197-204, 1993.
263. PENDURTHI, U.R., ALOK, D. and RAO, L.V.M. Cellular signalling mediated by binding of factor VIIa to tissue factor receptor. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1074), 1995.
264. BJØRKLID, E., STORM-MATHISEN, J., STORM, E. and PRYDZ, H. Localization of tissue thromboplastin in the human brain. Thromb Haemost 37, 91-97, 1977.
265. SPORN, L.A., HAIDARIS, P.J., SHI, R.J., NEMERSON, Y., SILVERMAN, D.J. and MARDER, V.J. Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression. Blood 83(6), 1527-1534, 1994.
266. TEYSSEIRE, N., ARNOUX, D., GEORGE, F., SAMPOL, J. and RAOULT, D. Von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells. Infect Immun 60(10), 4388-4393, 1992.
267. LYBERG, T., CLOSS, O. and PRYDZ, H. Effect of purified protein derivative and sonicates of Mycobacterium leprae and Mycobacterium bovis BCG on thromboplastin response in human monocytes in vitro. Infect Immun 38(3), 855-859, 1982.
268. HEMMER, C.J., KERN, P., HOLST, F.G., RADTKE, K.P., EGBRING, R., BIERHAUS, A., NAWROTH, P.P. and DIETRICH, M. Activation of the host response in human Plasmodium falciparum malaria: Relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels. Am J Med 97(1), 37-44, 1991.
269. BRANCH, D.W. and RODGERS, G.M. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: A possible mechanism of thrombosis. Am J Obstet Gynecol 168(1), 206-210, 1993.
270. KORNBERG, A., BLANK, M., KAUFMAN, S. and SHOENFELD, Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 153(3), 1328-1332, 1994.
271. LEVY, G.A., LEIBOWITZ, J.L. and EDGINGTON, T.S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med 154(4), 1150-1163, 1981.
272. LYBERG, T. and PRYDZ, H. Lectin stimulation of tissue thromboplastin activity in human monocytes in vitro. Thromb Haemost 42(5), 1574-1579, 1980.
273. LYBERG, T. and PRYDZ, H. Phorbol esters induce synthesis of thromboplastin activity in human monocytes. Biochem J 194(3), 699-706, 1981.
274. DEAN, R.T. and PRYDZ, H. Amines induce increased thromboplastin activity in human monocytes. Eur J Biochem 131(3), 655-658, 1983.
275. BROX, J.H., ØSTERUD, B., BJØRKLID, E. and FENTON, J.W., II. Production and availability of thromboplastin in endothelial cells: The effects of thrombin, endotoxin and platelets. Br J Haematol 57(2), 239-246, 1984.
276. GALDAL, K.S., LYBERG, T., EVENSEN, S.A., NILSEN, E. and PRYDZ, H. Thrombin induces thromboplastin synthesis in cultured vascular endothelial cells. Thromb Haemost 54(2), 373-376, 1985.
277. BEVILACQUA, M.P., POBER, J.S., MAJEAU, G.R., COTRAN, R.S. and GIMBRONE, M.A., JR. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160(2), 618-623, 1984.
278. CARLSEN, E., FLATMARK, A. and PRYDZ, H. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation 46(4), 575-580, 1988.
279. BEVILACQUA, M.P., POBER, J.S., MAJEAU, G.R., FIERS, W., COTRAN, R.S. and GIMBRONE, M.A., JR. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83(12), 4533-4537, 1986.
280. CLAUSS, M., GERLACH, M., GERLACH, H., BRETT, J., WANG, F., FAMILLETTI, P.C., PAN, Y.C., OLANDER, J.V., CONNOLLY, D.T. and STERN, D. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172(6), 535-545, 1990.
281. PRYDZ, H., LYBERG, T., DETEIX, P., ALLISON, A.C. In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins. Thromb Res 15(3-4), 465-474, 1979.
282. TANNENBAUM, S.H., FINKO, R. and CINES, D.B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 737(5), 1532-1537, 1986.
283. PRYDZ, H., ALLISON, A.C. and SCHORLEMMER, H.U. Further link between complement activation and blood coagulation. Nature 270(5633), 173-174, 1977.
284. GALDAL, K.S. Thromboplastin synthesis in endothelial cells. Haemostasis 14(5), 378-385, 1984.
285. CERMAK, J., KEY, N.S., BACH, R.R., BALLA, J., JACOB, H.S. and VERCELLOTTI, G.M. C-Reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82(2), 513-520, 1993.
286. SCHUFF-WERNER, P., CLAUS, G., ARMSTRONG, V.W., KOSTERING, H. and SEIDEL, D. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis 75(2-3), 109-112, 1989.
287. DRAKE, T.A., HANNANI, K., FEI, H.H., LAVI, S. and BERLINER, J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 138(3), 601-607, 1991.
288. LESNIK, P., ROUIS, M., SKARLATOS, S., KRUTH, H.S. and CHAPMAN, M.J. Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci USA 89(21), 10370-10374, 1992.
289. FAUCETTE, K.J., PARKER, C.J., MC CLUSKEY, T., BERNSHAW, N.J. and RODGERS, G.M. Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma. Blood 79(11), 2888-2895, 1992.
290. KORNBERG, A., CATANE, R., PELLER, S., KAUFMAN, S. and FRIDKIN, M. Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines. Blood 76(4), 814-819, 1990.
291. CRUTCHLEY, D.J. and QUE, B.G. Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants. Circulation 92(2), 238-243, 1995.
292. SIEGBAHN A. and ERNOLFSSON, M. Platelet-derived growth factor-BB and monocyte chemoattractant protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Haemost, Suppl, XIVth International Congress on Thrombosis and Haemostasis (abstract 1077), 1995.
293. CARLSEN, E., GAUDERNACK, G., FILION-MYKLEBUST, C., PETTERSEN, K.S. and PRYDZ, H. Allogenic induction of thromboplastin synthesis in monocytes and endothelial cells. Biphasic effect of cyclosporin A. Clin Exp Immunol 76(3), 428-433, 1989.
294. GERTLER, J.P., WEIBE, D.A., OCASIO, V.H. and ABBOTT, W.M. Hypoxia induces procoagulant activity in cultured human venous endothelium. J Vasc Surg 13(3), 428-433, 1991.
295. DEAN, R.T and PRYDZ, H. Inflammatory particles stimulate thromboplastin production by human monocytes. Thromb Res 30(4), 357-367, 1983.